The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Open accessAbstract
Transforming growth factor-β (TGF-β) is a central player in fibrotic disease. Clinical trials with global inhibitors of TGF-β have been disappointing, suggesting that a more targeted approach is warranted. Conversion of the latent precursor to the biologically active form of TGF-β represents a novel approach to selectively modulating TGF-β in disease, as mechanisms employed to activate latent TGF-β are typically cell, tissue, and/or disease specific. In this review, we will discuss the role of the matricellular protein, thrombospondin 1 (TSP-1), in regulation of latent TGF-β activation and the use an antagonist of TSP-1 mediated TGF-β activation in a number of diverse fibrotic diseases. In particular, we will discuss the TSP-1/TGF-β pathway in fibrotic complications of diabetes, liver fibrosis, and in multiple myeloma. We will also discuss emerging evidence for a role for TSP-1 in arterial remodeling, biomechanical modulation of TGF-β activity, and in immune dysfunction. As TSP-1 expression is upregulated by factors induced in fibrotic disease, targeting the TSP-1/TGF-β pathway potentially represents a more selective approach to controlling TGF-β activity in disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Sanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174
Self-citationQuigley, H. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61423-7 · Cited by 1,121
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023
Latent TGF-β structure and activation
Shi, M., Zhu, J., Wang, R., Chen, X., Mi, L., Walz, T., & Springer, T. A. (2011) · Nature · doi:10.1038/nature10152 · Cited by 1,013
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 756
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1
Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J. L., Munger, J. S., Kawakatsu, H., Sheppard, D., Broaddus, V. C., & Nishimura, S. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109100 · Cited by 729
Protection from obesity and diabetes by blockade of TGF-β/smad3 signaling
Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.013 · Cited by 709
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
Hinz, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.05.006 · Cited by 608
TGF‐β signalling and liver disease
Fabregat, I., Moreno‐Càceres, J., Sánchez, A., Dooley, S., Dewidar, B., Giannelli, G., ten Dijke, P., & the IT‐LIVER Consortium (2016) · The FEBS Journal · doi:10.1111/febs.13665 · Cited by 600
Integrins and the activation of latent transforming growth factor β1 – An intimate relationship
Wipff, P.-J., & Hinz, B. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.01.012 · Cited by 517
TGF-β – an excellent servant but a bad master
Kubiczkova, L., Sedlarikova, L., Hajek, R., & Sevcikova, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-183 · Cited by 511
Latent transforming growth factor-β: Structural features and mechanisms of activation
Munger, J. S., Harpel, J. G., Gleizes, P.-E., Mazzieri, R., Nunes, I., & Rifkin, D. B. (1997) · Kidney International · doi:10.1038/ki.1997.188 · Cited by 511
Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice
Travis, M. A., Reizis, B., Melton, A. C., Masteller, E., Tang, Q., Proctor, J. M., Wang, Y., Bernstein, X., Huang, X., Reichardt, L. F., et al. (2007) · Nature · doi:10.1038/nature06110 · Cited by 503
Schultz-Cherry, S. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.4.923 · Cited by 468
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
Adams, J. C., & Lawler, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009712 · Cited by 457
Denton (2007) · doi:10.1002/art.22289 · Cited by 447
Regulation of Transforming Growth Factor-β Activation by Discrete Sequences of Thrombospondin 1
Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Krutzsch, H. C., Roberts, D. D., & Murphy-Ullrich, J. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7304 · Cited by 424
Self-citationPrud'homme, G. J. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700669 · Cited by 419
Tumor suppressor activity of the TGF-β pathway in human cancers
Markowitz, S. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00001-9 · Cited by 416
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
Revisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
Self-citationPathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy
Ziyadeh, F., & Wolf, G. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502370 · Cited by 383
Ribeiro, S. M. F., Poczatek, M., Schultz-Cherry, S., Villain, M., & Murphy-Ullrich, J. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13586 · Cited by 353
Self-citationComplexities of TGF-β Targeted Cancer Therapy
Connolly, E. C., Freimuth, J., & Akhurst, R. J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4564 · Cited by 345
Jobling, M. F., Mott, J. D., Finnegan, M. T., Jurukovski, V., Erickson, A. C., Walian, P. J., Taylor, S. E., Ledbetter, S., Lawrence, C. M., Rifkin, D. B., et al. (2006) · Radiation Research · doi:10.1667/rr0695.1 · Cited by 300
The role of TGF-β in the pathogenesis of primary open-angle glaucoma
Fuchshofer, R., & Tamm, E. R. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1274-7 · Cited by 288
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
Voelker, J., Berg, P. H., Sheetz, M., Duffin, K., Shen, T., Moser, B., Greene, T., Blumenthal, S. S., Rychlik, I., Yagil, Y., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111230 · Cited by 275
Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II Diabetes
Sharma, K., Ziyadeh, F. N., Alzahabi, B., McGowan, T. A., Kapoor, S., Kurnik, B. R. C., Kurnik, P. B., & Weisberg, L. S. (1997) · Diabetes · doi:10.2337/diab.46.5.854 · Cited by 274
Schultz-Cherry, S., Ribeiro, S., Gentry, L., & Murphy-Ullrich, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47086-x · Cited by 272
Self-citationTGF-β signaling in the kidney: profibrotic and protective effects
Sureshbabu, A., Muhsin, S. A., & Choi, M. E. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00365.2015 · Cited by 267
The Single-Molecule Mechanics of the Latent TGF-β1 Complex
Buscemi, L., Ramonet, D., Klingberg, F., Formey, A., Smith-Clerc, J., Meister, J.-J., & Hinz, B. (2011) · Current Biology · doi:10.1016/j.cub.2011.11.037 · Cited by 257
Transforming growth factor-beta complexes with thrombospondin.
Murphy-Ullrich, J. E., Schultz-Cherry, S., & Höök, M. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.181 · Cited by 257
Self-citationThe type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry, S., Lawler, J., & Murphy-Ullrich, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47087-1 · Cited by 248
Self-citationInfluenza virus neuraminidase activates latent transforming growth factor beta
Schultz-Cherry, S., & Hinshaw, V. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8624-8629.1996 · Cited by 244
Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms
Sweetwyne, M. T., & Murphy-Ullrich, J. E. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.006 · Cited by 241
Self-citationTransforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells
Urashima, M., Ogata, A., Chauhan, D., Hatziyanni, M., Vidriales, M., Dedera, D., Schlossman, R., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.5.1928.1928 · Cited by 235
Aluwihare, P., Mu, Z., Zhao, Z., Yu, D., Weinreb, P. H., Horan, G. S., Violette, S. M., & Munger, J. S. (2009) · Journal of Cell Science · doi:10.1242/jcs.035246 · Cited by 225
Ma, L.-J., Yang, H., Gaspert, A., Carlesso, G., Barty, M. M., Davidson, J. M., Sheppard, D., & Fogo, A. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63486-4 · Cited by 215
Worthington, J. J., Kelly, A., Smedley, C., Bauché, D., Campbell, S., Marie, J. C., & Travis, M. A. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.012 · Cited by 199
Angiotensin II sustains brain inflammation in mice via TGF-β
Lanz, T. V., Ding, Z., Ho, P. P., Luo, J., Agrawal, A. N., Srinagesh, H., Axtell, R., Zhang, H., Platten, M., Wyss-Coray, T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41709 · Cited by 198
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Hypoxia‐induced increase in the production of extracellular matrix proteins in systemic sclerosis
Distler, J. H. W., Jüngel, A., Pileckyte, M., Zwerina, J., Michel, B. A., Gay, R. E., Kowal‐Bielecka, O., Matucci‐Cerinic, M., Schett, G., Marti, H. H., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23074 · Cited by 193
Transforming growth factor-β1 and diabetic nephropathy
Chang, A. S., Hathaway, C. K., Smithies, O., & Kakoki, M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00502.2015 · Cited by 190
Yehualaeshet, T., O'Connor, R., Green-Johnson, J., Mai, S., Silverstein, R., Murphy-Ullrich, J. E., & Khalil, N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65183-8 · Cited by 180
Self-citationAdd-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat
Benigni, A., Zoja, C., Corna, D., Zatelli, C., Conti, S., Campana, M., Gagliardini, E., Rottoli, D., Zanchi, C., Abbate, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000074238.61967.b7 · Cited by 176
The integrin αVβ6 binds and activates latent TGFβ3
Annes, J. P., Rifkin, D. B., & Munger, J. S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03280-x · Cited by 173
Obesity and Diabetic Kidney Disease
Maric-Bilkan, C. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.010 · Cited by 173
Cellular response to hypoxia involves signaling via Smad proteins
Zhang, H., Akman, H. O., Smith, E. L., Zhao, J., Murphy-Ullrich, J. E., & Batuman, O. (2003) · Blood · doi:10.1182/blood-2002-02-0629 · Cited by 171
Self-citationA four‐gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis
Farina, G., Lafyatis, D., Lemaire, R., & Lafyatis, R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27220 · Cited by 170
Hoffman, B. B., Sharma, K., Zhu, Y., & Ziyadeh, F. N. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00119.x · Cited by 168
Liver Fibrosis: From Pathogenesis to Novel Therapies
Weiskirchen, R., & Tacke, F. (2016) · Digestive Diseases · doi:10.1159/000444556 · Cited by 167
TGF-β signaling in liver and gastrointestinal cancers
Katz, L. H., Likhter, M., Jogunoori, W. S., Belkin, M. D., Ohshiro, K., & Mishra, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.033 · Cited by 148
Kirwan, R. P., Fenerty, C., Crean, J. K. G., Wordinger, R. J., Clark, A. F., & O'Brien, C. J. (2005) · PubMed · Cited by 147
Kumar, R., Mickael, C. S., Kassa, B., Gebreab, L., Robinson, J. C., Koyanagi, D. E., Sanders, L., Barthel, L., Meadows, C. A., Fox, D. L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15494 · Cited by 145
Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo
Daniel, C., Wiede, J., Krutzsch, H. C., Ribeiro, S. M. F., Roberts, D. D., Murphy-Ullrich, J. E., & Hugo, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00395.x · Cited by 142
Self-citationTGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review)
Yoshida, K., MURATA, M., Yamaguchi, T., & Matsuzaki, K. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2552 · Cited by 142
Regulation of TGFβ in the immune system: An emerging role for integrins and dendritic cells
Worthington, J. J., Fenton, T. M., Czajkowska, B. I., Klementowicz, J. E., & Travis, M. A. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.06.009 · Cited by 140
Wahab, N. A., Schaefer, L., Weston, B. S., Yiannikouris, O., Wright, A., Bábelová, A., Schaefer, R. M., & Mason, R. M. (2005) · Diabetologia · doi:10.1007/s00125-005-0006-5 · Cited by 139
TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
Takeuchi, K., Abe, M., Hiasa, M., Oda, A., Amou, H., Kido, S., Harada, T., Tanaka, O., Miki, H., Nakamura, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009870 · Cited by 138
Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice
Chen, S., de la Cruz, M. D. C. I., Jim, B., Hong, S. W., Isono, M., & Ziyadeh, F. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02708-0 · Cited by 137
Ruscetti, F. W., Akel, S. M., & Bartelmez, S. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208921 · Cited by 130
The role of transforming growth factor β in glaucoma and the therapeutic implications
Prendes, M. A., Harris, A., Wirostko, B. M., Gerber, A., & Siesky, B. A. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301132 · Cited by 127
Elevated Plasma Levels of Transforming Growth Factor-β1 in NIDDM
Pfeiffer, A. F. H., Middelberg-Bisping, K., Drewes, C., & Schatz, H. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1113 · Cited by 126
Melton, A. C., Bailey-Bucktrout, S. L., Travis, M. A., Fife, B. T., Bluestone, J. A., & Sheppard, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43786 · Cited by 126
Belmadani, S., Bernal, J., Wei, C., Pallero, M. A., Dell’Italia, L. J., Murphy-Ullrich, J. E., & Berecek, K. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070056 · Cited by 122
Self-citationWang, A., Ziyadeh, F. N., Lee, E. Y., Pyagay, P. E., Sung, S. H., Sheardown, S. A., Laping, N. J., & Chen, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00274.2007 · Cited by 121
Flügel‐Koch, C., Ohlmann, A., Fuchshofer, R., Welge‐Lüßen, U., & Tamm, E. R. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.07.005 · Cited by 120
Molecular Interactions That Confer Latency to Transforming Growth Factor-β
Young, G. D., & Murphy-Ullrich, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405658200 · Cited by 118
Self-citationZhou, Y., Poczatek, M. H., Berecek, K. H., & Murphy-Ullrich, J. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.060 · Cited by 114
Self-citationWang, S., Skorczewski, J., Feng, X., Mei, L., & Murphy-Ullrich, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401629200 · Cited by 112
Self-citationHayashi, T., Hideshima, T., Nguyen, A. N., Munoz, O., Podar, K., Hamasaki, M., Ishitsuka, K., Yasui, H., Richardson, P., Chakravarty, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0632 · Cited by 110
Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice
Hathaway, C. K., Gasim, A., Grant, R., Chang, A. S., Kim, H., Madden, V. J., Bagnell, C. R., Jennette, J. C., Smithies, O., & Kakoki, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504777112 · Cited by 109
Thrombospondin-1 Is an Endogenous Activator of TGF-β in Experimental Diabetic Nephropathy In Vivo
Daniel, C., Schaub, K., Amann, K., Lawler, J., & Hugo, C. (2007) · Diabetes · doi:10.2337/db07-0551 · Cited by 106
Poczatek, M. H., Hugo, C., Darley-Usmar, V. M., & Murphy-Ullrich, J. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64649-4 · Cited by 105
Self-citationThe role of matricellular proteins in glaucoma
Wallace, D., Murphy-Ullrich, J. E., Downs, J. C., & O'Brien, C. J. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.03.007 · Cited by 105
Self-citationWalton, K. L., Makanji, Y., Chen, J. B., Wilce, M. C. J., Chan, K. K. L., Robertson, D. M., & Harrison, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110288 · Cited by 102
The role of TGF-beta signaling in dendritic cell tolerance
Esebanmen, G. E., & Langridge, W. H. R. (2017) · Immunologic Research · doi:10.1007/s12026-017-8944-9 · Cited by 101
Changes in the Biomechanical Response of the Optic Nerve Head in Early Experimental Glaucoma
Roberts, M. D., Sigal, I. A., Liang, Y., Burgoyne, C. F., & Downs, J. C. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5411 · Cited by 100
Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome
Matsuo, Y., Tanaka, M., Yamakage, H., Sasaki, Y., Muranaka, K., Hata, H., Ikai, I., Shimatsu, A., Inoue, M., Chun, T., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.016 · Cited by 100
A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo
Kondou, H., Mushiake, S., Etani, Y., Miyoshi, Y., Michigami, T., & Ozono, K. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00377-5 · Cited by 99
TGF-β-related mechanisms of bone destruction in multiple myeloma
Matsumoto, T., & Abe, M. (2010) · Bone · doi:10.1016/j.bone.2010.05.036 · Cited by 98
Li, Y., Tong, X., Rumala, C., Clemons, K., & Wang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026656 · Cited by 98
Seliger, C., Leukel, P., Moeckel, S., Jachnik, B., Lottaz, C., Kreutz, M. P., Brawanski, A. T., Proescholdt, M. A., Bogdahn, U., Bosserhoff, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078935 · Cited by 94
Lu, A., Miao, M., Schoeb, T. R., Agarwal, A., & Murphy-Ullrich, J. E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.039 · Cited by 94
Self-citationThrombospondin-1 Is the Key Activator of TGF-β1 in Human Mesangial Cells Exposed to High Glucose
Yevdokimova, N. Y., Wahab, N. A., & Mason, R. M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v124703 · Cited by 92
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
Weller, M., Nabors, B., Gorlia, T., Leske, H., Rushing, E. J., Bady, P., Hicking, C., Perry, J., Hong, Y.-K., Roth, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7588 · Cited by 91
Young, G. D., & Murphy-Ullrich, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404918200 · Cited by 89
Self-citationKirwan, R. P., Wordinger, R. J., Clark, A. F., & O'Brien, C. J. (2009) · PubMed Central · Cited by 89
Ma, L.-J., Jha, S. S., Ling, H., Pozzi, A., Ledbetter, S., & Fogo, A. B. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00381.x · Cited by 88
O'Brien, C. J., Kirwan, R. P., Fenerty, C., Crean, J. K. G., Wordinger, R. J., & Clark, A. F. (2006) · Journal of Biomechanics · doi:10.1016/s0021-9290(06)84552-5 · Cited by 87
Wang, S., Shiva, S., Poczatek, M. H., Darley-Usmar, V. M., & Murphy-Ullrich, J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108360200 · Cited by 86
Self-citationHayashi, H., Sakai, K., Baba, H., & Sakai, T. (2011) · Hepatology · doi:10.1002/hep.24800 · Cited by 84
Muñoz‐Félix, J. M., González-Núñez, M., Martínez‐Salgado, C., & López-Novoa, J. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.003 · Cited by 84
Connolly, E. C., Saunier, E. F., Quigley, D., Luu, M. T., De Sapio, A., Hann, B., Yingling, J. M., & Akhurst, R. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2941 · Cited by 82
Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma
Danielsen, J. M. R., Knudsen, L. M., Dahl, I. M. S., Lodahl, M., & Rasmussen, T. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06729.x · Cited by 81
Distribution of integrin subunits in human diabetic kidneys.
Jin, D., Fish, A. J., Wayner, E. A., Mauer, M. S., Setty, S., Tsilibary, E. C., & Kim, Y. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122636 · Cited by 80
Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy
Johnson, S. A., & Spurney, R. F. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00266.2015 · Cited by 79
Yehualaeshet, T., O'Connor, R. N., Begleiter, A., Murphy-Ullrich, J. E., Silverstein, R. L., & Khalil, N. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.2.4089 · Cited by 78
Self-citationBreitkopf, K., Sawitza, I., Westhoff, J. H., Wickert, L., Dooley, S., & Gressner, A. M. (2005) · Gut · doi:10.1136/gut.2004.042911 · Cited by 77
Role of thrombospondin 1 in liver diseases
Li, Y., Turpin, C., & Wang, S. (2016) · Hepatology Research · doi:10.1111/hepr.12787 · Cited by 77
Lu, A., Pallero, M. A., Lei, W., Hong, H., Yang, Y., Suto, M. J., & Murphy-Ullrich, J. E. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.003 · Cited by 75
Self-citationTGF-β1 and TGF-β2 abundance in liver diseases of mice and men
Dropmann, A., Dediulia, T., Breitkopf‐Heinlein, K., Korhonen, H., Janicot, M., Weber, S. N., Thomas, M., Piiper, A., Bertrán, E., Fabregat, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6967 · Cited by 75
Smalling, R. V., Delker, D. A., Zhang, Y., Nieto, N., McGuiness, M., Liu, S., Friedman, S. L., Hagedorn, C. H., & Wang, L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00077.2013 · Cited by 74
Perspectives on biomechanical growth and remodeling mechanisms in glaucoma
Grytz, R., Girkin, C. A., Libertiaux, V., & Downs, J. C. (2012) · Mechanics Research Communications · doi:10.1016/j.mechrescom.2012.01.007 · Cited by 72
Pharmacologic Blockade of αvβ1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo
Chang, Y., Lau, W. L., Jo, H., Tsujino, K., Gewin, L. S., Reed, N. I., Atakilit, A., Nunes, A. C. F., DeGrado, W. F., & Sheppard, D. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050585 · Cited by 72
Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1
Kim, C. W., Paskaleva, A., Kumar, S., Timmins, L. H., Morris, A. D., Kang, D. W., Dalal, S., Chadid, T., Kuo, K. M., Raykin, J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026361 · Cited by 71
Macko, R. F., Gelber, A. C., Young, B. A., et al. (2002) · PubMed · Cited by 70
Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction
Bigé, N., Shweke, N., Benhassine, S., Jouanneau, C., Vandermeersch, S., Dussaule, J., Chatziantoniou, C., Ronco, P. M., & Boffa, J. (2012) · Kidney International · doi:10.1038/ki.2012.21 · Cited by 67
Benzoubir, N., Lejamtel, C., Battaglia, S., Testoni, B., Benassi, B., Gondeau, C., Perrin‐Cocon, L., Desterke, C., Thiers, V., Samuel, D., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.036 · Cited by 66
Fenton, T. M., Kelly, A., Shuttleworth, E. E., Smedley, C., Atakilit, A., Powrie, F., Campbell, S., Nishimura, S. L., Sheppard, D., Levison, S., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.94 · Cited by 64
Chen, X., Yang, Y.-A., Zhou, Q., Weiss, J. M., Howard, O. Z., McPherson, J. M., Wakefield, L. M., & Oppenheim, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085398 · Cited by 62
Pierson, B., Gupta, K., Hu, W.-S., & Miller, J. S. (1996) · Blood · doi:10.1182/blood.v87.1.180.bloodjournal871180 · Cited by 61
Krishna, S. M., Seto, S. W., Jose, R. J., Biroš, E., Moran, C. S., Wang, Y., Clancy, P., & Golledge, J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304732 · Cited by 61
Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice
Soto‐Pantoja, D. R., Shih, H. B., Maxhimer, J. B., Cook, K. L., Ghosh, A., Isenberg, J. S., & Roberts, D. D. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.05.003 · Cited by 60
Characterization of integrin ?6 and thrombospondin-1 double-null mice
Ludlow, A., Yee, K. O., Lipman, R. D., Bronson, R. T., Weinreb, P. H., Huang, X., Sheppard, D., & Lawler, J. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00367.x · Cited by 59
Role of Thrombospondin-1 in T Cell Response to Ocular Pigment Epithelial Cells
Futagami, Y., Sugita, S., Vega, J. L., Ishida, K., Takase, H., Maruyama, K., Aburatani, H., & Mochizuki, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6994 · Cited by 58
BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice
Fan, Y., Li, X., Xiao, W., Fu, J., Harris, R. C., Lindenmeyer, M., Cohen, C. D., Guillot, N., Baron, M. H., Wang, N., et al. (2015) · Diabetes · doi:10.2337/db14-1397 · Cited by 57
Pathophysiology of Obesity-Related Renal Dysfunction Contributes to Diabetic Nephropathy
Bayliss, G. P., Weinrauch, L. A., & D’Elia, J. A. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0288-1 · Cited by 54
Thrombospondins in physiology and disease: New tricks for old dogs
Murphy-Ullrich, J. E., & Iozzo, R. V. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.002 · Cited by 53
Self-citationChanges in the gene expression programs of renal mesangial cells during diabetic nephropathy
Brunskill, E. W., & Potter, S. S. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-70 · Cited by 53
DuBose, K. B., Zayzafoon, M., & Murphy-Ullrich, J. E. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.020 · Cited by 50
Self-citationYang, K., Vega, J. L., Hadzipasic, M., Peron, J. P. S., Zhu, B., Carrier, Y., Masli, S., Rizzo, L. V., & Weiner, H. L. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.12.004 · Cited by 50
Ahamed, J., Janczak, C. A., Wittkowski, K. M., & Coller, B. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006608 · Cited by 50
Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity
Cui, W., Maimaitiyiming, H., Qi, X., Norman‐Burgdolf, H., & Wang, S. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00209.2013 · Cited by 50
Yamashita, T., Asano, Y., Taniguchi, T., Nakamura, K., Saigusa, R., Miura, S., Toyama, T., Takahashi, T., Ichimura, Y., Yoshizaki, A., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.037 · Cited by 50
Therapeutic Strategies in the Treatment of Diabetic Nephropathy - a Translational Medicine Approach
Shah, I. M., Mackay, S. P., & McKay, G. A. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581897 · Cited by 49
Hohenstein, B., Daniel, C., Hausknecht, B., Boehmer, K., Riess, R. H., Amann, K., & Hugo, C. P. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn399 · Cited by 49
Xie, X., Li, F., Liu, H., Deng, Y. L., Li, Z., & Fan, J. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0213-6 · Cited by 48
Chen, Y., Leask, A., Abraham, D., Kennedy, L., Shiwen, X., Denton, C. P., Black, C. M., Verjee, L. S., & Eastwood, M. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-9 · Cited by 47
El‐Youssef, M., Mu, Y., Huang, L., Stellmach, V. M., & Crawford, S. E. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199904000-00008 · Cited by 46
Noble, P. W. (2003) · PubMed · Cited by 44
Kuroki, H., Hayashi, H., Nakagawa, S., Sakamoto, K., Higashi, T., Nitta, H., Hashimoto, D., Chikamoto, A., Beppu, T., & Baba, H. (2015) · British journal of surgery · doi:10.1002/bjs.9765 · Cited by 44
Mikuła‐Pietrasik, J., Sosińska, P., Janus, J., Rubiś, B., Brewińska‐Olchowik, M., Piwocka, K., & Książek, K. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.004 · Cited by 40
HGF regulates the activation of TGF‐β1 in rat hepatocytes and hepatic stellate cells
Narmada, B. C., Chia, S., Tucker‐Kellogg, L., & Yu, H. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24143 · Cited by 40
Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin
Yang, Y., Chuang, L., Guh, J., Shu-Fen, L. I. U., Hung, M., Liao, T., & Huang, Y.-L. (2004) · Biochemical Journal · doi:10.1042/bj20031730 · Cited by 36
Sugar, Sex, and TGF-β in Diabetic Nephropathy
Diamond-Stanic, M. K., You, Y. H., & Sharma, K. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.005 · Cited by 35
Tsujino, K., Reed, N. I., Atakilit, A., Ren, X., & Sheppard, D. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00428.2016 · Cited by 35
Mir, F. A., Contreras‐Ruiz, L., & Masli, S. (2015) · Immunology · doi:10.1111/imm.12517 · Cited by 34
Obesity and kidney disease: Beyond the hyperfiltration
Mascali, A., Franzese, O., Nisticò, S. P., Campia, U., Lauro, D., Cardillo, C., Daniele, N. D., & Tesauro, M. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016643550 · Cited by 33
Daniel, C., Wagner, A., Hohenstein, B., & Hugo, C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00254.2009 · Cited by 32
Ruscetti, F. W., & Bartelmez, S. H. (2001) · International Journal of Hematology · doi:10.1007/bf02982545 · Cited by 31
Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury
Liu, S., Shi, L., & Wang, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00316.2007 · Cited by 30
Yang, G., Geng, X., Liu, Z., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.623421 · Cited by 29
Harpel, J. G., Schultz‐Cherry, S., Murphy-Ullrich, J. E., & Rifkin, D. B. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4922 · Cited by 29
Self-citationInteraction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy
Cui, W., Maimaitiyiming, H., Zhou, Q., Norman‐Burgdolf, H., Zhou, C., & Wang, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.010 · Cited by 28
Avouac, J., Clemessy, M., Distler, J. H. W., Gasc, J. M., Ruiz, B., Vacher‐Lavenu, M., Wipff, J., Kahan, A., Boileau, C., Corvol, P. L., et al. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/keq448 · Cited by 27
BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
Maile, L. A., Gollahon, K. A., Wai, C., Dunbar, P. R., Busby, W. H., & Clemmons, D. R. (2014) · Journal of Diabetes Research · doi:10.1155/2014/421827 · Cited by 26
Hafdi, Z., Lesavre, P., Nejjari, M., et al. (2000) · Cell Communication & Adhesion · doi:10.3109/15419060009040302 · Cited by 24
Zeisberg, M., Tampe, B., LeBleu, V. S., Tampe, D., Zeisberg, E. M., & Kalluri, R. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.06.014 · Cited by 24
Novel avenues for treating diabetic nephropathy: new investigational drugs
Lacava, V., Pellicanò, V., Ferrajolo, C., Cernaro, V., Visconti, L., Conti, G., Buemi, M., & Santoro, D. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1293039 · Cited by 24
The Thrombospondin1-TGF-β Pathway and Glaucoma
Murphy-Ullrich, J. E., & Downs, J. C. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0016 · Cited by 23
Self-citationMyung, S. J., Yoon, J., Gwak, G., Kim, W. K., Yang, J. I., Lee, S. H., Jang, J. J., & Lee, H.-S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.157 · Cited by 23
Glomerulopathy in the KK.Cg-Ay/J Mouse Reflects the Pathology of Diabetic Nephropathy
O’Brien, S., Smith, M., Ling, H., Phillips, L. A., Weber, W., Lydon, J. T., Maloney, C., Ledbetter, S. R., ARBEENY, C. M., & Wawersik, S. (2013) · Journal of Diabetes Research · doi:10.1155/2013/498925 · Cited by 21
Mesangial cell αvβ8-integrin regulates glomerular capillary integrity and repair
Lakhe-Reddy, S., Li, V., Arnold, T. D., Khan, S., & Schelling, J. R. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00624.2013 · Cited by 21
Reed, N. I., Tang, Y., McIntosh, J. E., Wu, Y., Molnar, K. S., Civitavecchia, A., Sheppard, D., DeGrado, W. F., & Jo, H. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00196 · Cited by 21
Takeyama, H., Mizushima, T., Uemura, M., Haraguchi, N., Nishimura, J., Hata, T., Matsuda, C., Takemasa, I., Ikenaga, M., Murata, K., et al. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4578-y · Cited by 21
Sun, H. Q., Zhao, Y., Bi, X., Li, S., Su, G., Miao, Y., Ma, X., Zhang, Y., Zhang, W., & Zhong, M. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0246-8 · Cited by 20
Gene expression patterns in glucose-stimulated podocytes
Han, S. H., Yang, S., Jung, D. S., Li, J. J., Kim, J., Kwak, S. J., Kim, D. K., Moon, S. J., Lee, J. E., Han, D. S., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.121 · Cited by 19
Sugaru, E., Nakagawa, T., Ono‐Kishino, M., Nagamine, J., Tokunaga, T., Kitoh, M., Hume, W. E., Nagata, R., & Taiji, M. (2006) · Nephron Experimental Nephrology · doi:10.1159/000097603 · Cited by 18
Thrombospondin1 Deficiency Attenuates Obesity-Associated Microvascular Complications in ApoE-/- Mice
Maimaitiyiming, H., Clemons, K., Zhou, Q., Norman‐Burgdolf, H., & Wang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121403 · Cited by 17
Sugaru, E., Nakagawa, T., Ono‐Kishino, M., Nagamine, J., Tokunaga, T., Kitoh, M., Hume, W. E., Nagata, R., & Taiji, M. (2006) · American Journal of Nephrology · doi:10.1159/000091786 · Cited by 16
Production of Gastrointestinal Tumors in Mice by Modulating Latent TGF-β1 Activation
Shibahara, K., Ota, M., Horiguchi, M., Yoshinaga, K., Melamed, J., & Rifkin, D. B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3141 · Cited by 16
Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β
Willet, J. D. P., Pichitsiri, W., Jenkinson, S. E., Brain, J. G., Wood, K. M., Alhasan, A. A., Spielhofer, J., Robertson, H., Ali, S., & Kirby, J. A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712324 · Cited by 11
Cited by
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
Younesi, F. S., Miller, A. E., Barker, T. H., Rossi, F. M. V., & Hinz, B. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00716-0 · Cited by 681
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Metadata
- Authors
- Murphy-Ullrich, J. E., & Suto, M. J.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 68-69
- Pages
- 28-43
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2779950914
- Cited by
- 332
- References
- 176
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.